How to Buy Arcus Biosciences Stock
Arcus Biosciences Inc
Arcus Biosciences is a biotech company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker RCUS on the NYSE exchange.
Arcus Biosciences stock last closed at $7.71, down 2.16% from the previous day, and has decreased 47.48% in one year. It has overperformed other stocks in the Biotechnology industry by 0.3 percentage points. Arcus Biosciences stock is currently +18.62% from its 52-week low of $6.50, and -59.38% from its 52-week high of $18.98.
There are currently 105.84M shares of RCUS outstanding. The market value of RCUS is $816.04M. In the past 24 hours, 1.16M RCUS shares were traded.
How to Buy Arcus Biosciences Stock
Wondering how to invest in Arcus Biosciences stock? Here's how.
- Figure out where to buy Arcus Biosciences stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you figure out where to buy Arcus Biosciences stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Put funds into your investment account: Select your method of payment and add your info.
- Analyze Arcus Biosciences stock: The Arcus Biosciences ticker symbol is RCUS. Is Arcus Biosciences stock a good investment? Should you buy shares of RCUS? How do RCUS's underlying business fundamentals look? Do top analysts think Arcus Biosciences is a good buy? Why has RCUS's stock price moved recently? (Hint: Our stock research tools can help you evaluate if RCUS is a good stock to buy).
- Execute your RCUS trade: Decide if you will purchase RCUS shares at the current market price or use a limit order to purchase RCUS shares at a specific price.
- Track your RCUS position: Create a watchlist to important notifications about your position in Arcus Biosciences stock.
Step 1: Figure out where to buy Arcus Biosciences stock
You will need an online brokerage account in order to access the NYSE market and buy RCUS stock.
Our preferred brokerage: eToro
Based on our research, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the best brokerage, you need to fill out some personal details so you can buy RCUS stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to start your new trading account.
- Send your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've filled out your info on the best stock app, your next step is to transfer the money for your investment:
Watch the walkthrough below if you need help transferring money into your new brokerage account.
Step 4: Analyze Arcus Biosciences stock
After you have chosen the best place to buy Arcus Biosciences stock, it's important to evaluate their stock prior to buying, so you can understand the risk as well as the upside.
Arcus Biosciences Metrics
RCUS Due Diligence Checks
WallStreetZen was built to help average investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on RCUS's stock page.
What is the fair value of RCUS stock?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge RCUS's intrinsic value.
Using relative valuations measures:
- RCUS could be undervalued based on its P/B ratio of 1.68x, relative to Biotechnology industry P/B ratio of 4.04x
You can do additional valuation analysis on RCUS's stock here.
How do RCUS Financials look?
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the RCUS balance sheet.
- RCUS has $978.00M in cash and short term investments. This is sufficient to cover its annual cash burn of $176.00M.
- RCUS has cash burn of 176000000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the RCUS balance sheet.
Failed Health Checks:
- RCUS has a relatively high debt to equity ratio of 1.37.
- RCUS profit margin has gone up by 1.53 percentage points in the past year, but the company is still unprofitable.
- Total RCUS debt is higher than 5 years ago, relative to shareholder equity.
Do analysts think it's a good time to buy RCUS stock
Out of 4 sell side analysts who track RCUS, the consensus analyst rating on Arcus Biosciences is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Arcus Biosciences stock forecast page.
Metrics for Advanced RCUS Traders
RCUS Performance Numbers
Last year, RCUS revenue was $258.00M. During the last 5 year, RCUS's revenue has increased by 76.65% per year. This was faster than the Biotechnology industry average of 44.31%.
Find out more about RCUS's earnings and revenue performance here.
Latest Insiders Trades at RCUS
Over the past 12 months, insiders at RCUS have bought more shares than they have sold.
Yasunori Kaneko, Director of RCUS, was the latest RCUS insider to buy. They bought $201,200.00 worth of RCUS shares on Feb 27, 2025.
Get more info about who owns RCUS stock here.
Does RCUS provide a stable income stream?
No, Arcus Biosciences doesn't provide an income stream by paying out dividends.
What others are saying about RCUS
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your RCUS trade
You have two primary options:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually sufficient. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a given price, place a limit order.
Press the Open button and your broker will execute your order.
If you want additional info about buying stocks on eToro, click the helpful video below:
Step 6: Track your RCUS position
Now that you own some shares in RCUS, you'll want to keep up with your new investment.
Start a watchlist to see the latest developments about your RCUS stock.
RCUS Feed
How to Buy Stock in Arcus Biosciences
To reiterate, here are the 6 steps to buy stock in Arcus Biosciences:
- Figure out where to buy Arcus Biosciences stock
- Sign up for a brokerage account
- Put funds into your investment account
- Analyze Arcus Biosciences stock
- Execute your RCUS trade
- Track your RCUS position
If you are looking for a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Arcus Biosciences, create your watchlist below.
More "How To" Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.